Literature DB >> 8861827

3(3) factorial design-based optimization of the formulation of nitrofurantoin microcapsules.

H Y Karasulu1, G Ertan, T Günerï.   

Abstract

A microcapsule form of nitrofurantoin was prepared by a simple coacervation method with carboxymethylcellulose and aluminium sulfate. 3(3) factorial design was performed for three independent variables, namely, the particle size of the drug, the size of the microcapsules and the pH of the dissolution medium. The dissolution tests with the formulated microcapsules were carried out according to the United States Pharmacopeia XXII rotating basket method at pH 1.2, 5, and 7.5, which represent the pH of gastrointestinal fluids. Release data were examined kinetically and the ideal kinetic models were estimated and t(63.2) values obtained from RRSBW distribution were used in the factorial design experiment. The influence of the independent variables on the dissolution of nitrofurantoin microcapsules could be expressed as the pH of the dissolution medium > particle size of the microcapsule > particle size of nitrofurantoin. The other aim of this study was to evaluate microcapsule formulation in terms of the United States Pharmacopeia criteria with a minimum of experiments. Our findings suggest that dosage forms which comply with the pharmacopoeia criteria for dissolution can be prepared and selected by factorial design.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861827     DOI: 10.1007/bf00449685

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  17 in total

1.  Use of adsorbents in enhancement of drug dissolution. I.

Authors:  D C Monkhouse; J L Lach
Journal:  J Pharm Sci       Date:  1972-09       Impact factor: 3.534

2.  Dissolution profile of log-normal powders: exact expression.

Authors:  D Brooke
Journal:  J Pharm Sci       Date:  1973-05       Impact factor: 3.534

3.  In vitro dissolution and in vivo absorption of nitrofurantoin from deoxycholic acid coprecipitates.

Authors:  R G Stoll; T R Bates; J Swarbrick
Journal:  J Pharm Sci       Date:  1973-01       Impact factor: 3.534

4.  A practical guide to drug usage in adult patients with impaired renal function.

Authors:  W M Bennett; I Singer; C H Coggins
Journal:  JAMA       Date:  1970-11-23       Impact factor: 56.272

5.  Optimization of conditions for preparing 2- to 5-micron-range gelatin microparticles by using chilled dehydration agents.

Authors:  L Oner; M J Groves
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

6.  Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.

Authors:  G Ertan; E Karasulu; M Abou-Nada; M Tosun; A Ozer
Journal:  J Microencapsul       Date:  1994 Mar-Apr       Impact factor: 3.142

7.  Effect of formulation and process variables on bioequivalency of nitrofurantoin I: preliminary studies.

Authors:  R W Mendes; S Z Masih; R R Kanumuri
Journal:  J Pharm Sci       Date:  1978-11       Impact factor: 3.534

8.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

9.  Laboratory studies with nitrofurantoin. Relationship between crystal size, urinary excretion in the rat and man, and emesis in dogs.

Authors:  H E Paul; K J Hayes; M F Paul; A R Borgmann
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

10.  Urinary excretion in the rat of nifurpipone (NP) and of nitrofurantoin (NTF) administered by different routes.

Authors:  M Veronese; M Salvaterra; D Barzaghi; I Setnikar
Journal:  Arzneimittelforschung       Date:  1974-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.